Auro Laboratories (BOM:530233) Net Issuance of Preferred Stock : ₹0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Auro Laboratories's net issuance of preferred for the three months ended in Dec. 2024 was ₹0.0 Mil. The number is 0, which means that Auro Laboratories has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Auro Laboratories's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.0 Mil.

Auro Laboratories Net Issuance of Preferred Stock Historical Data

The historical data trend for Auro Laboratories's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Net Issuance of Preferred Stock Chart

Auro Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Auro Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Auro Laboratories Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Auro Laboratories Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Auro Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

N/A

Address

S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030

Website

http://www.aurolabs.com

Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines